SCH 58261 (an adenosine A2A receptor antagonist) reduces, only at low doses, K+-evoked glutamate release in the striatum

This publication has 21 references indexed in Scilit:

• Inhibition of evoked glutamate release by the neuroprotective 5-HT1A receptor agonist BAY x 3702 in vitro and in vivo
  Brain Research, 2001
• Adenosine receptors in neurological disorders
  Emerging Therapeutic Targets, 2000
• Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats
  NeuroReport, 2000
• Is Pharmacological Neuroprotection Dependent on Reduced Glutamate Release?
  Stroke, 2000
• Brain Adenosine Receptors as Targets for Therapeutic Intervention in Neurodegenerative Diseases
  Annals of the New York Academy of Sciences, 1999
• Striatal A2A adenosine receptors differentially regulate spontaneous and K+-evoked glutamate release in vivo in young and aged rats
  NeuroReport, 1999
• Activation of the A_2A adenosine receptor inhibits nitric oxide production in glial cells
  FEBS Letters, 1998
• Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists
  Neuroscience, 1998
• Effects of adenosine derivatives on human and rabbit platelet aggregation
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1992
• The Role of Glutamate Neurotoxicity in Hypoxic-Ischemic Neuronal Death
  Annual Review of Neuroscience, 1990